DAFTAR

PUSTAKA

Al-Saif SM, Al-Habib KF, Ullah A, Hersi, AlFaleh H, Alnemer K et al. Age and
its relationship to acute coronary syndromes in the Saudi Project for
Assessment of Coronary Events (SPACE) registry: The SPACE age study.
J Saudi Heart Assoc.2011;8:1-8.
Alexander KP et al. Acute coronary care in the elderly, part I:
non-ST-segment-elevation acute coronary syndromes: a scientific
statement for healthcare professionals from the American Heart
Association Council on Clinical Cardiology: in collaboration with the
Society of Geriatric Cardiology. Circulation. 2007;115(19):254969.
Antithrombotic Trialists Collaboration. Collaborative meta-analysis of
randomised trials of antiplatelet therapy for prevention of death,
myocardial infarction, and stroke in high risk patients.
BMJ.2002;324(7329):71-86.
Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al.
ACC/AHA guidelines for the management of patients with ST-elevation
myocardial infarction: a report of the American College of
Cardiology/American Heart Association Task Force on Practice
Guidelines. J. Am. Coll. Cardiol. 2008;51;210-247
Antman EM, Cohen M, Bernink J. L, McCabe CH, Horacek, Papuchis G et al.The
TIMI risk score for unstable angina/non-ST elevation MI: A method for
prognostication and therapeutic decision making. JAMA. 2000; 284:
835-42.
Antman EM . In Braunwalds Heart Disease A Text Book of Cardiovascular
Medicine ST-Segment Elevation Myocardial Infarction: Pathology,
Pathophysiology, and Clinical Features. 9th edition,2005: p.1098-1105.
Antoni ML, Bertini M, Atary JZ, Delgado V, Ellen AB, Boersma E et al.
Predictive Value of Total Atrial Conduction Time Estimated with Tissue
Doppler Imaging for the Development of New-Onset Atrial Fibrillation
after Acute Myocardial Infarction. Am J Cardiol.2010;106: 198-203.
Arnon BM, Julia S and Yonathan H. Leukocytes and acute myocardial infarction.
IMAJ 2002;4:1060-5.
Bilal A, Sindhu GA, Qureshi FS, Iqbal J. Predictive Value of Blood Glucose as an
Independent Risk factor for Progression/ Mortality in Acute Coronary
Syndrome. A.P.M.C.2007;1:19-25.

Universitas Sumatera Utara

Braunwald E. Unstable angina: A classification. Circulation.1989;80:410-4.

Boersma E, Maas AC, Deckers JW, Simons ML. Early thrombolytic treatment in
acute myocardial infarction reappraisal of the golden hour.
Lancet.1996;348:771-5
Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door-to-balloon
time in acute myocardial infarction. N Engl J Med.2006;355:2308 20.
Brodie BR, Stone GW, Morice MC, Cox DA, Garcia E, Mattos LA, et al.
Importance of time to reperfusion on outcomes with primary coronary
angioplasty for acute myocardial infarction (results from the Stent
Primary Angioplasty in Myocardial Infarction Trial). Am J
Cardiol.2001;88:1085-90.
Budaj A, David B, Gabriel S, Shaun GG, Omar HD,Keith AA, et al. Global
patterns of use of antithrombotic and antiplatelet therapies in patients
with acute coronary syndromes: Insights from the Global Registry of
Acute Coronary Events (GRACE).Am Heart J. 2003;146:999-1006.
Carlo DM. Treatment of acute myocardial infarction in Europe: Review of current
models and proposal of optimal common standards ESC STEMI
Guidelines 2011. Diunduh dari : www.escardio.org/EAPCI.
Chen ZM, Pan HC, Chen YP , Peto R, Collins R, Jiang LX, et al. Early
intravenous then oral metoprolol in 45,852 patients with acute
myocardial infarction: randomised placebo-controlled trial.COMMIT
(ClOpidogrel and Metoprolol in Myocardial Infarction Trial)
collaborative group. Lancet.2005;366:1622-32.
Christenson RH, Duh SH, Newby LK, Ohman EM, Califf RM, Granger CB, et al.
Cardiac troponin T and cardiac troponin I: relative values in short-term
risk stratification of patients with acute coronary syndromes. GUSTO-IIa
Investigators. Clin Chem.1998;44:494-501.
Christopher PC, Braunwald E . In Braunwalds Heart Disease A Text Book of
Cardiovascular Medicine : Unstable Angina and NonST Elevation
Myocardial Infarction. 9th edition, 2005:p.1189-1220.
Cole DR, Singian EB, Kate LN. The long-term prognosis following myocardial
infarction, and some factors which affect it. Circulation. 1954;9:321-34
David

OW. Treatment delayed

2004;109:1806-09.

is

treatment

denied.

Circulation.

Universitas Sumatera Utara

De Luca G, Suryapranata H, Ottervanger JP, et al. Time delay to treatment and

mortality in primary angioplasty for acute myocardial infarction: every
minute of delay counts. Circulation. 2004;109:122325.
Deckelbaum L.Chapter 11: Heart attacks and coronary artery disease. p.133-146.
Di
unduh
dari: http://www.pdfpedia.com/download/6925/heart-attacks-and-coronar
y-artery-disease-pdf.html.
Eagle KA, Fox KA, Gore JM, Steg PG, Anderson FA, GRACE and GRACE-2
Investigators. The Global Registry of Acute Coronary Events,1999 to
2009 GRACE. Heart. 2010;96:1095-101
Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S.
Unfractionated heparin and low-molecular-weight heparin in acute
coronary syndrome without ST elevation: a meta-analysis. Lancet.
2000;355:1936-42.
Findlay IN, Cunningham AD. Definition of acute coronary syndrome. Heart.
2005;91(7):857-9.
Fibrinolytic Therapy Trialists (FTT) Collaborative
fibrinolytic therapy in suspected acute
collaborative overview of early mortality and
from all randomised trials of more than
1994;343:311-22.

Group. Indications for

myocardial infarction:
major morbidity results
1000 patients. Lancet

Foo RSY, De Bono DP. Concepts in Acute Coronary Syndromes. Singapore Med J.
2000;41(12):606-610.
Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, et al. Benefits and
risks of the combination of clopidogrel and aspirin in patients undergoing
surgical revascularization for non-ST-elevation acute coronary syndrome:
the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events
(CURE) Trial. Circulation.2004;110(10):1202-8.
Francisco JG, Juan RG, Manuel V, Luis M, Eugenia S,Francisca T et al. Use of a
Coronary Risk Score (the TIMI Risk Score) in a Non-Selected Patient
Population Assessed for Chest Pain at an Emergency Department. Rev
Esp Cardiol.2005;58:775-81.
Go AS, Barron HV, Rundle AC, Ornato JP, Avins AL. Bundle-branch block and
in-hospital mortality in acute myocardial infarction. National Registry of

Universitas Sumatera Utara

Myocardial Infarction
1998;129(9):690-7.

Investigators.

Ann

Intern

Med

Hamm WC, Heeschen C, Falk E, Fox KAA. Acute coronary syndrome :

Pathophysiology, Diagnosis and risk stratification. Elsevier.
2004:p.333-367.
Huon GH, Keith DD, John MM, Iain AS. Lecture notes cardiology, Edisi
4.Erlangga Medical Series, Jakarta;2002:107-50.
Jacobs DR Jr, Kroenke C, Crow R, et al. PREDICT: a simple risk score for
clinical severity and long-term prognosis after hospitalization for acute
myocardial infarction or unstable angina: the Minnesota Heart Survey.
Circulation.1999;100:599-607.
Katz R & Henry P. In Clinical Practice Series : Acute Coronary Syndromes. 1st
edition. Elsevier,2006: p.10-45
Kaul P, Newby LK, Yuling Fu, Hasselblad V, Mahaffey KW, Christenson RH et al.
Troponin T and quantitative ST-Segment depression offer complementary
prognostic information in the risk stratification of acute coronary
syndrome patients. J Am Coll Cardiol. 2003;41:371 80.
Koon-Hou M, Topol EJ. Emerging concepts in the management of acute
myocardial infarction in patients with diabetes mellitus.J Am Coll
Cardiol.2000;35:5638.
Krumholz HM, Chen J, Wang Y, et al. Comparing AMI mortality among hospitals
in patients 65 years of age and older: evaluating methods of risk
adjustment. Circulation. 1999;99:298692.
Lakhani MS, Qadir F, Hanif B, Farooq S, Khan M. Correlation of Thrombolysis in
Myocardial Infarction (TIMI) risk score with extent of coronary artery
disease
in
patients
with
acute
coronary
syndrome.
JPMA.2010;60:197-201.
Levine GN, Eric RB, James CB, Steven RB, John A, Bojan C et al. 2011
ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention : A
Report of the American College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines and the Society for
Cardiovascular
Angiography
and
Interventions.
Circulation.
2011;124:1-82.
Libby P. Molecular basis of the acute coronary syndromes. Circulation.

Universitas Sumatera Utara

1995;91:2844-2850.
Luepker RV, Apple FS, Christenson RH et al. Case Definitions for Acute
Coronary Heart Disease in Epidemiology and Clinical Research Studies.
Circulation. 2003;108:2543-49.
Luciano B, Jaffe AS. Troponin: the biomarker of choice for the detection of
cardiac injury. CMAJ .2005;173:1191-202.
Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, et al.
Randomized trial of insulin-glucose infusion followed by subcutaneous
insulin treatment in diabetic patients with acute myocardial infarction
(DIGAMI study): effects on mortality at 1 year. J Am Coll
Cardiol.1995;26(1):57-65
Manoharan G, Ntalianis A, Muller O, Hamilos M,Sarno G, Melikian N. Severity
of coronary arterial stenoses responsible for acute coronary syndromes. J
Am Coll Cardiol.2009;103:11838.
Marc SS, Elliott MA.The Thrombolysis In Myocardial Infarction Risk Score in
Unstable Angina/NonST-Segment Elevation Myocardial Infarction. J
Am Coll Cardiol.2003;41:89-95.
Milaveta JJ, Geibel DW, Christian TF, et al. Time to therapy and salvage in
myocardial infarction. J Am Coll Cardiol.1998;31:124651.
Morrow AD, Antman EA, Parsons L , de Lemos J, Cannon CP, Giugliano RP,et al.
Application of the TIMI risk score for ST-Elevation MI in the National
Registry of Myocardial Infarction 3. JAMA.2001;286:1356-9.
Morrow AD, Antman EM, Charlesworth A, et al.TIMI risk score for ST-elevation
myocardial infarction: a convenient, bedside, clinical score for risk
assessmentat presentation: an InTIME II trial substudy.Circulation.
2000;102:2031-37.
Mueller C, Neumann FJ , Perruchoud AP, Buettner HJ. White blood cell count and
long term mortality after non-ST elevation acute coronary syndrome
treated with very early revascularization.Heart.2003;89:38992.
Munir TA, Afzal MN. Assessment of differential leukocyte count in patients with
acute coronary syndrome.JPMA.2010;60:548-52.
Newby LK, Goldmann UB, Ohman EU.Troponin: An Important Prognostic
Marker and Risk-Stratification Tool in NonST-Segment Elevation Acute

Universitas Sumatera Utara

Coronary Syndromes. J Am Coll Cardiology. 2003;41:31S36S.

Nunez J, Lorenzo F, ngel L, Juan S, Vicent B, Vicente B et al. Prognostic value
of white blood cell count in acute myocardial infarction: Long-Term
mortality. Rev Esp Cardiol. 2005;58:631-9.
Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for
risk stratification in acute myocardial ischemia. GUSTO IIA
Investigators. N Engl J Med.1996;335:1333-41.
Perhimpunan Dokter Spesialis Kardiovaskuler Indonesia. Pedoman Tatalaksana
Penyakit Kardiovaskuler di Indonesia. Edisi ke-3;2012:3-54.

Pollack CV Jr., Sites FD, Shofer FS, Sease KL, Hollander JE et al. Application of
the TIMI Risk Score for Unstable Angina and Non-ST Elevation Acute
Coronary Syndrome to an Unselected Emergency Department Chest Pain
Population. Academic Emergency Medicine. 2006;13:1318.
Palwasha S, Khan AA, Sahibzada WA. The Impact of Hyperglycaemia on
Morbidity and mortality of Acute Coronary Syndromes and Acute
Myocardial Infarction. J Ayub Med Coll Abbottabad Pakistan. 2009;
21:110-5
Rathore SS, Weinfurt KP, Foody JM and Krumholz HM. Performance of the
thrombolysis in myocardial infarction (TIMI) ST-elevation myocardial
infarction risk score in a national cohort of elderly patients. Am Heart J.
2005;150:40210.
Rationale and design of the GRACE (Global Registry of Acute Coronary Events)
Project: a multinational registry of patients hospitalized with acute
coronary syndromes. Am Heart J .2001;141(2):190-9.
Roxana M, Stuart JP, Gregg WS, Tim CC, George DD, Frederick F et al.
Associations of major bleeding and myocardial infarction with the
incidence and timing of mortality in patients presenting with
non-ST-elevation acute coronary syndromes: a risk model from the
ACUITY trial. European Heart Journal.2009;30:145766.
Saman R, Jan PO, Jan-Henk E D, Menko BJ, Jan CA, Marcel G et al. Are patients
with non-ST elevation myocardial infarction undertreated? BMC
Cardiovascular Disorders.2007;7:1-8.
Sabatine MS, Cannon CP, Gibson CM, Lpez-Sendn JL, Montalescot G, Theroux
P, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for

Universitas Sumatera Utara

myocardial infarction with ST-segment elevation. N Engl J Med.

2005;352:1179-89
Sacks FM, Pfeffer MA, Moye LA.The effect of pravastatin on coronary events
after myocardial infarction in patients with average choleterol levels. N
Engl J Med.1996;3:1001-9.
Scirica BM, et al. Unstable Angina/Non-segmen ST-Elevasi Myocard Infark .
Data from TIMI III Registr. J Am Coll Cardiol.2002:29-41.
Scottish Intercollegiate Guidelines Network (SIGN). Acute coronary syndromes :
A national clinical guideline.1st published.2007:p.1-59. Diunduh
dari : www.sign.ac.uk.
Sean MS, Garrick CS, Carolyn HM, Satishkumar M, Sabina AM, Christopher PC.
Diabetes and Mortality Following Acute Coronary Syndromes.
JAMA.2007;298:765-75.
Sohby M, Antepara N, Escobar, Alam, Leizorovicz A, Martinez C. Management
of acute coronary syndromes in developing countries: The ACCESS
registry.
Diunduh
dari
http://www.escardio.org/congresses/esc-2010/congress-reports/
Documents/Monday/ACCESS-presenter-slides-Sobhy.pdf
Soiza RL, Leslie SJ, Williamson P,Wai S, Harrild K, Peden NR and Hargreaves
AD.Risk stratification in acute coronary syndromesdoes the TIMI risk
score work in unselected cases? Q J Med.2006;99:817.
Theroux P, Welsh RC. Meta-analysis of randomized trials comparing enoxaparin
versus unfractionated heparin as adjunctive therapy to fibrinolysis in
ST-elevation acute myocardial infarction. Am J Cardiol. 2003;
91(7):860-4.
Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM and
Pajak.A. Myocardial infarction and coronary deaths in the World Health
Organization MONICA Project. Registration procedures, event rates, and
case-fatality rates in38 populations from 21 countries in four continents.
Circulation.1994;90:583-612.
van der Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, et al.
Management of acute myocardial infarction in patients presenting with
ST-segment elevation. The Task Force on the Management of Acute
Myocardial Infarction of the European Society of Cardiology. Eur Heart
J. 2003;24(1):28-66.

Universitas Sumatera Utara

Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1

year after an invasive compared with a non-invasive strategy in unstable
coronary-artery disease: the FRISC II invasive randomised trial. FRISC
II Investigators. Fast Revascularisation during Instability in Coronary
artery disease. Lancet 2000;356(9223):9-16.
Wright RS, Cynthia DA, Jeffrey LA, Theodore GG, Donald EC, Jr, Steven ME et
al. 2011 ACCF/AHA Focused Update of the Guidelines for the
Management of Patients With Unstable Angina/Non_ST-Elevation
Myocardial Infarction (Updating the 2007 Guideline. J. Am. Coll.
Cardiol. 2011;57;1920-1959.
Wong GC, Giugliano RP, Antman EM. Use of low-molecular-weight heparins in
the management of acute coronary artery syndromes and percutaneous
coronary intervention. JAMA.2003;289(3):331-42.
Yusuf S, Mehta SR, Zhao F, Gersh BJ, Commerford PJ , Blumenthal M, et al.
Early and late effects of clopidogrel in patients with acute coronary
syndromes. Circulation. 2003;107:966-72.
Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in
heart disease. II. Unstable angina, heart failure,primary prevention with
aspirin, and risk factor modification. JAMA.1988;260:2259-63.
Zijlstra F, Patel A, Jones M, Grines CL, Ellis S, Garcia E, Grinfeld L. Clinical
characteristics and outcome of patients with early (<2 h), intermediate
(24 h) and late (>4 h) presentation treated by primary coronary
angioplasty or thrombolytic therapy for acute myocardial infarction.
European Heart Journal.2002;23:5507

Universitas Sumatera Utara